Status:
COMPLETED
Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients
Lead Sponsor:
Novartis
Conditions:
Liver Transplant
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether cyclosporine microemulsion given once a day instead of twice a day benefits kidney function, blood pressure, lipid profile and glucose control in stab...
Eligibility Criteria
Inclusion
- At least 6 months post-transplant
- At least one of the following: stable or deteriorating kidney function, high blood pressure, high lipids, high glucose
- Receiving stable doses of cyclosporine microemulsion for the past 3 months
Exclusion
- \- Severe rejection within the past 3 months
- Severe kidney dysfunction
- Transplanted for hepatitis C or autoimmune hepatitis
- Other protocol-defined exclusion criteria applied
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2005
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT00171509
Start Date
May 1 2004
End Date
October 1 2005
Last Update
February 1 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.